BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Irmscher S, Zipfel SLH, Halder LD, Ivanov L, Gonzalez-Delgado A, Waldeyer C, Seiffert M, Brunner FJ, von der Heide M, Löschmann I, Wulf S, Czamara D, Papac-Milicevic N, Strauß O, Lorkowski S, Reichenspurner H, Holers MV, Banda NK, Zeller T, Binder EB, Binder CJ, Wiech T, Zipfel PF, Skerka C. Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease. Sci Rep 2021;11:22511. [PMID: 34795372 DOI: 10.1038/s41598-021-02011-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Alic L, Binder CJ, Papac-milicevic N. The OSE complotype and its clinical potential. Front Immunol 2022;13:1010893. [DOI: 10.3389/fimmu.2022.1010893] [Reference Citation Analysis]
2 Yu H, Wang C, Ke S, Bai M, Xu Y, Lu S, Feng Z, Qian B, Xu Y, Zhou M, Li Z, Yin B, Li X, Hua Y, Zhou Y, Pan S, Fu Y, Ma Y. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. Front Immunol 2022;13:892750. [DOI: 10.3389/fimmu.2022.892750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Li X, Zong J, Si S. Complement Factor H related protein 1 and immune inflammatory disorders. Molecular Immunology 2022;145:43-9. [DOI: 10.1016/j.molimm.2022.03.117] [Reference Citation Analysis]
4 Kiss MG, Binder CJ. The multifaceted impact of complement on atherosclerosis. Atherosclerosis 2022. [DOI: 10.1016/j.atherosclerosis.2022.03.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]